Skip to main content

Erythema Multiforme

James R. Yon, MD and Justin D Leavitt, MD Reviewed 05/2023
 


BASICS

  • Erythema multiforme (EM) is an uncommon, self-limiting, immune-mediated, mucocutaneous disease.

    • Approximately 90% of cases are triggered by infectious agents (herpes simplex virus is most common...

DIAGNOSIS

  • Diagnosis is based on history and clinical findings, and most cases do not require further work-up.

  • In unclear cases, histopathologic analysis including immunofluorescence microscopy and othe...

TREATMENT

GENERAL MEASURES

  • Treatment will depend on disease severity, underlying cause, and course of the disease.

  • Determine the level of care: outpatient versus inpatient.

  • Determine the cause of EM ...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

The disease is self-limiting. Complications are rare, with no mortality. 

PATIENT EDUCATION

Avoid any identified etiologic agents. 

PROGNOSIS

Rash e...

REFERENCES

1
Trayes KP, Love G, Studdiford JS. Erythema Multiforme: Recognition and Management. Am Fam Physician. 2019;100(2):82–88. [View Abstract on OvidMedline]
2
de Risi-Pugliese ...

SEE ALSO

Cutaneous Drug Reactions; Dermatitis Herpetiformis; Pemphigoid Gestationis; Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis; Urticaria 

CODES

ICD10

  • L51.0 Nonbullous erythema multiforme

  • L51.1 Stevens-Johnson syndrome

  • L51.3 Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome

  • L51.9 Erythema multiforme, unspecified

  • L51.2 Toxic...

CLINICAL PEARLS

EM is diagnosed clinically. No lab tests are required for the diagnosis. Typical lesions are targetoid or “iris.” Lesions are symmetrical. Recurrent cases often due to HSV, and antivir...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×